That's true even though Amevive, for psoriasis, and Zevalin, for lymphoma, have been small sellers for Biogen.

FORBES: Biogen Idec Hits A Nerve

Spectrum is conducting late-stage studies for the use of Zevalin in treatments for other types of lymphoma.

FORBES: Straightforward Talk From Spectrum Pharmaceuticals Helps Attract Investors

Now, the patient will receive two infusions of rituximab about a week apart, followed by an infusion of only Yttrium 90-Zevalin.

FORBES: Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

On Nov. 18, 2011, the FDA approved the removal of what is a major obstacle to physician adoption and use of Zevalin.

FORBES: Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

Specifically, the FDA okayed the removal of a bioscan requirement for Zevalin, making it more convenient for lymphoma patients to receive treatment with the drug.

FORBES: Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

Prior to the FDA action, patients were required to get an infusion of rituximab the first day, followed by a pre-treatment diagnostic dose of radiolabeled indium-111 Zevalin.

FORBES: Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

Apart from its anti-cancer drugs Fusilev and Zevalin, Spectrum has 10 other oncology drug candidates that are now in clinical development, two of them in phase 3 clinical trials and several undergoing phase 1 and 2 clinical studies.

FORBES: Why This Tiny But Profitable Biotech May Be Gobbled Up By Big Pharma